Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 19505257.
- Also identified by DOI 10.1086/599837 and PMC identifier 3724235.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The ability of cytotoxic T lymphocytes (CTLs) to clear virus-infected cells is dependent on the presentation of viral peptides processed intracellularly and displayed by major histocompatibility complex class I. Most CTL functional assays use exogenously added peptides, a practice that does not account for the kinetics and quantity of antigenic peptides produced by infectable cells. Here, we examined the relative ability of 2 major human immunodeficiency virus-infectable cell subsets-CD4 T lymphocytes and monocytes-to produce antigenic peptides, using cytosol as a source of peptidases and mass spectrometry to define the degradation products. We show clear subset-specific differences in the kinetics of peptide production and the ability of the peptides produced to sensitize cells for lysis by CTLs, with primary CD4 T lymphocytes having significantly lower proteolytic activity than monocytes. These differences in epitope processing by cell subsets may affect the efficiency of CTL-mediated clearance of infected subsets and contribute to the establishment of chronic infection.
Medical subject headings
- Antigen Presentation
- CD4-Positive T-Lymphocytes
- Epitopes
- HIV
- Monocytes
- T-Lymphocytes, Cytotoxic